CD68 and Alzheimer disease: The analysis of apoptosis rates and the yield of proportions of well-differentiated CD68+ MDMs confirmed an expected increase of both when glycolysis was inhibited, which was particularly consistent in the highly glycolysis-dependent AD cells (Fig. 5m, o).